3 | SEC Filings Hub

Filing metadata

Accession number: 0001127602-25-021055
Form type: Form 3
Filer: Apellis Pharmaceuticals, Inc.
CIK: CIK 1492422
Filed: Sep 02, 2025
Reporting period: Aug 26, 2025
Description: Initial ownership

Documents

0001127602-25-021055-index.htm

Complete submission

0001127602-25-021055.txt

directory listing

Filed by

Apellis Pharmaceuticals, Inc.